PMID: 6971090Apr 1, 1981Paper

Chemotherapy for advanced carcinoma of the head and neck. A clinical update

Archives of Otolaryngology
T J ErvinM Meshad

Abstract

Optimal therapy for stage III and stage IV squamous carcinoma arising in the head and neck requires a multidisciplinary approach, including chemotherapy. Advances have identified several chemotherapeutic agents and combinations of agents that show substantial antitumor activity in this disease. While antitumor activity can be documented, experience indicates the duration of antitumor effect is short, and the toxicity may limit further therapy. To date, studies have not shown an advantage of combination chemotherapy over single agents. Theoretically, combination chemotherapy should increase patient survival through regression of the primary tumor as well as ablation of distant metastases. An analysis of recent trials with patients who received induction chemotherapy before definitive local treatment suggests that regression of tumor in stage III and stage IV lesions before definitive therapy may increase local treatment for regional disease. Randomized trials are needed to confirm or disprove the efficacy of combination chemotherapy for advanced squamous carcinoma of the head and neck.

Citations

Nov 1, 1984·The Journal of Laryngology and Otology·S BahadurS K Kacker
Apr 1, 1985·The Australian and New Zealand Journal of Surgery·I E HainesH M Rundle
Jan 1, 1983·Acta Oto-laryngologica·J WennerbergA Biörklund

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.